Rowan T Chlebowski1, Aaron K Aragaki2, Garnet L Anderson2, Kathy Pan1, Marian L Neuhouser2, JoAnn E Manson3, Cynthia A Thomson4, Yasmin Mossavar-Rahmani5, Dorothy S Lane6, Karen C Johnson7, Jean Wactawski-Wende8, Linda Snetselaar9, Thomas E Rohan5, Juhua Luo10, Ana Barac11, Ross L Prentice2. 1. Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA. 2. Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA. 3. Brigham and Women's Hospital, Harvard Medical School, Boston, MA. 4. Department of Nutritional Sciences, University of Arizona, Tucson, AZ. 5. Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY. 6. Department of Family, Population and Preventive Medicine, Stony Brook University School of Medicine, Stony Brook, NY. 7. Departments of Preventive Medicine and Medicine, University of Tennessee, Memphis, TN. 8. Department of Epidemiology and Environmental Health, University at Buffalo, Buffalo, NY. 9. College of Public Health, University of Iowa, Iowa City, IA. 10. Department of Epidemiology and Biostatistics, Indiana University, Bloomington, IN. 11. MedStar Heart and Vascular Institute, Georgetown University, Washington, DC.
Abstract
PURPOSE: Observational studies of dietary fat intake and breast cancer have reported inconsistent findings. This topic was addressed in additional analyses of the Women's Health Initiative (WHI) Dietary Modification (DM) clinical trial that evaluated a low-fat dietary pattern influence on breast cancer incidence. METHODS: In the WHI DM trial, 48,835 postmenopausal women, ages 50-79 years, with no prior breast cancer, and a dietary fat intake of ≥ 32% of energy were randomly assigned at 40 US centers to a usual diet comparison group (60%) or dietary intervention group (40%). The goals were to reduce fat intake to 20% of energy and increase vegetable, fruit, and grain intake. Breast cancers were confirmed after central medical record review and serial National Death Index linkages to enhance mortality findings. RESULTS: During 8.5 years of dietary intervention, breast cancer incidence and deaths as a result of breast cancer were nonsignificantly lower in the intervention group, while deaths after breast cancer were statistically significantly lower both during intervention and through a 16.1-year (median) follow-up. Now, after a long-term, cumulative 19.6-year (median) follow-up, the significant reduction in deaths after breast cancer persists (359 [0.12%] v 652 [0.14%] deaths; hazard ratio [HR], 0.85; 95% CI, 0.74 to 0.96; P = .01), and a statistically significant reduction in deaths as a result of breast cancer (breast cancer followed by death attributed to the breast cancer) emerged (132 [0.037%, annualized risk] v 251 [0.047%] deaths, respectively; HR, 0.79; 95% CI, 0.64 to 0.97; P = .02). CONCLUSION: Adoption of a low-fat dietary pattern associated with increased vegetable, fruit, and grain intake, demonstrably achievable by many, may reduce the risk of death as a result of breast cancer in postmenopausal women.
PURPOSE: Observational studies of dietary fat intake and breast cancer have reported inconsistent findings. This topic was addressed in additional analyses of the Women's Health Initiative (WHI) Dietary Modification (DM) clinical trial that evaluated a low-fat dietary pattern influence on breast cancer incidence. METHODS: In the WHI DM trial, 48,835 postmenopausal women, ages 50-79 years, with no prior breast cancer, and a dietary fat intake of ≥ 32% of energy were randomly assigned at 40 US centers to a usual diet comparison group (60%) or dietary intervention group (40%). The goals were to reduce fat intake to 20% of energy and increase vegetable, fruit, and grain intake. Breast cancers were confirmed after central medical record review and serial National Death Index linkages to enhance mortality findings. RESULTS: During 8.5 years of dietary intervention, breast cancer incidence and deaths as a result of breast cancer were nonsignificantly lower in the intervention group, while deaths after breast cancer were statistically significantly lower both during intervention and through a 16.1-year (median) follow-up. Now, after a long-term, cumulative 19.6-year (median) follow-up, the significant reduction in deaths after breast cancer persists (359 [0.12%] v 652 [0.14%] deaths; hazard ratio [HR], 0.85; 95% CI, 0.74 to 0.96; P = .01), and a statistically significant reduction in deaths as a result of breast cancer (breast cancer followed by death attributed to the breast cancer) emerged (132 [0.037%, annualized risk] v 251 [0.047%] deaths, respectively; HR, 0.79; 95% CI, 0.64 to 0.97; P = .02). CONCLUSION: Adoption of a low-fat dietary pattern associated with increased vegetable, fruit, and grain intake, demonstrably achievable by many, may reduce the risk of death as a result of breast cancer in postmenopausal women.
Authors: Victor M Montori; P J Devereaux; Neill K J Adhikari; Karen E A Burns; Christoph H Eggert; Matthias Briel; Christina Lacchetti; Teresa W Leung; Elizabeth Darling; Dianne M Bryant; Heiner C Bucher; Holger J Schünemann; Maureen O Meade; Deborah J Cook; Patricia J Erwin; Amit Sood; Richa Sood; Benjamin Lo; Carly A Thompson; Qi Zhou; Edward Mills; Gordon H Guyatt Journal: JAMA Date: 2005-11-02 Impact factor: 56.272
Authors: Jing Li Huang; Scott Kizy; Schelomo Marmor; Ariella Altman; Anne Blaes; Heather Beckwith; Todd M Tuttle; Jane Yuet Ching Hui Journal: Breast Cancer Res Treat Date: 2018-09-08 Impact factor: 4.872
Authors: Kala Visvanathan; Carol J Fabian; Elissa Bantug; Abenaa M Brewster; Nancy E Davidson; Andrea DeCensi; Justin D Floyd; Judy E Garber; Erin W Hofstatter; Seema A Khan; Maria C Katapodi; Sandhya Pruthi; Rachal Raab; Carolyn D Runowicz; Mark R Somerfield Journal: J Clin Oncol Date: 2019-09-03 Impact factor: 44.544
Authors: M J Stampfer; W C Willett; F E Speizer; D C Dysert; R Lipnick; B Rosner; C H Hennekens Journal: Am J Epidemiol Date: 1984-05 Impact factor: 4.897
Authors: Rowan T Chlebowski; Aaron K Aragaki; Garnet L Anderson; Michael S Simon; JoAnn E Manson; Marian L Neuhouser; Kathy Pan; Marcia L Stefanic; Thomas E Rohan; Dorothy Lane; Lihong Qi; Linda Snetselaar; Ross L Prentice Journal: JAMA Oncol Date: 2018-10-11 Impact factor: 31.777
Authors: Rowan T Chlebowski; Aaron K Aragaki; Garnet L Anderson; Cynthia A Thomson; JoAnn E Manson; Michael S Simon; Barbara V Howard; Thomas E Rohan; Linda Snetselar; Dorothy Lane; Wendy Barrington; Mara Z Vitolins; Catherine Womack; Lihong Qi; Lifang Hou; Fridtjof Thomas; Ross L Prentice Journal: J Clin Oncol Date: 2017-06-27 Impact factor: 44.544
Authors: C Davies; J Godwin; R Gray; M Clarke; D Cutter; S Darby; P McGale; H C Pan; C Taylor; Y C Wang; M Dowsett; J Ingle; R Peto Journal: Lancet Date: 2011-07-28 Impact factor: 79.321
Authors: Soo Youn Bae; Sangmin Kim; Jun Ho Lee; Hyun-Chul Lee; Se Kyung Lee; Won Ho Kil; Seok Won Kim; Jeong Eon Lee; Seok Jin Nam Journal: BMC Cancer Date: 2015-03-18 Impact factor: 4.430
Authors: Rowan T Chlebowski; Garnet L Anderson; JoAnn E Manson; Ross L Prentice; Aaron K Aragaki; Linda Snetselaar; Shirley A A Beresford; Lewis H Kuller; Karen Johnson; Dorothy Lane; Juhua Luo; Thomas E Rohan; Li Jiao; Ana Barac; Catherine Womack; Mace Coday; Mridul Datta; Cynthia A Thomson Journal: JNCI Cancer Spectr Date: 2019-01-07
Authors: Kathy Pan; Aaron K Aragaki; Marian L Neuhouser; Michael S Simon; Juhua Luo; Bette Caan; Linda Snetselaar; Joanne E Mortimer; JoAnn E Manson; Candyce Kroenke; Dorothy Lane; Kerryn Reding; Thomas E Rohan; Rowan T Chlebowski Journal: Br J Cancer Date: 2021-05-18 Impact factor: 7.640
Authors: Tengteng Wang; Maryam S Farvid; Jae H Kang; Michelle D Holmes; Bernard A Rosner; Rulla M Tamimi; Walter C Willett; A Heather Eliassen Journal: Cancer Res Date: 2021-06-09 Impact factor: 12.701